These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 1981824)

  • 21. Induction of CD56+ T cells after prolonged activation of T cells in vitro: a possible mechanism for CD4+ T-cell depletion in acquired immune deficiency syndrome patients.
    Takahashi M; Matsumura J; Inagaki S; Takahashi H
    Hum Immunol; 2011 Oct; 72(10):783-90. PubMed ID: 21741423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals.
    Connor RI; Mohri H; Cao Y; Ho DD
    J Virol; 1993 Apr; 67(4):1772-7. PubMed ID: 8095306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral Activity of HIV gp120-Targeting Bispecific T Cell Engager Antibody Constructs.
    Brozy J; Schlaepfer E; Mueller CKS; Rochat MA; Rampini SK; Myburgh R; Raum T; Kufer P; Baeuerle PA; Muenz M; Speck RF
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29720517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AIDS patient monocytes target CD4 T cells for cellular conjugate formation and deletion through the membrane expression of HIV-1 envelope molecules.
    Dudhane A; Wang ZQ; Orlikowsky T; Gupta A; Wormser GP; Horowitz H; Kufer P; Hoffmann MK
    AIDS Res Hum Retroviruses; 1996 Jul; 12(10):893-9. PubMed ID: 8798974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions.
    Holm GH; Gabuzda D
    J Virol; 2005 May; 79(10):6299-311. PubMed ID: 15858014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies.
    Zarling JM; Moran PA; Haffar O; Sias J; Richman DD; Spina CA; Myers DE; Kuebelbeck V; Ledbetter JA; Uckun FM
    Nature; 1990 Sep; 347(6288):92-5. PubMed ID: 1975641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral hyperactivation-limiting therapeutics as a novel class for the treatment of HIV/AIDS: focus on VS411.
    Uglietti A; Maserati R
    Expert Opin Investig Drugs; 2011 Apr; 20(4):559-65. PubMed ID: 21391888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TLR7 Agonist GS-9620 Is a Potent Inhibitor of Acute HIV-1 Infection in Human Peripheral Blood Mononuclear Cells.
    Bam RA; Hansen D; Irrinki A; Mulato A; Jones GS; Hesselgesser J; Frey CR; Cihlar T; Yant SR
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological mechanisms of interleukin-2 (IL-2) treatment in HIV/AIDS disease.
    Tincati C; d'Arminio Monforte A; Marchetti G
    Curr Mol Pharmacol; 2009 Jan; 2(1):40-5. PubMed ID: 20021444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire.
    Mukadi Y; Perriëns JH; St Louis ME; Brown C; Prignot J; Willame JC; Pouthier F; Kaboto M; Ryder RW; Portaels F
    Lancet; 1993 Jul; 342(8864):143-6. PubMed ID: 8101257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Deep lung--cellular reaction to HIV].
    Tavares Marques MA; Alves V; Duque V; Botelho MF
    Rev Port Pneumol; 2007; 13(2):175-212. PubMed ID: 17492233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptotic killing of CD4+ T lymphocytes in HIV-1-infected PHA-stimulated PBL cultures is mediated by CD8+ LAK cells.
    Wang L; Klimpel GR; Planas JM; Li H; Cloyd MW
    Virology; 1998 Feb; 241(2):169-80. PubMed ID: 9499792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis?
    Herbeuval JP; Shearer GM
    AIDS Rev; 2006; 8(1):3-8. PubMed ID: 16736946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonlymphoid reservoirs of HIV replication in children with chronic-progressive disease.
    Brodie SJ
    J Leukoc Biol; 2000 Sep; 68(3):351-9. PubMed ID: 10985251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Few infected CD4+ T cells but a high proportion of replication-competent provirus copies in asymptomatic human immunodeficiency virus type 1 infection.
    Brinchmann JE; Albert J; Vartdal F
    J Virol; 1991 Apr; 65(4):2019-23. PubMed ID: 1672165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human endothelial cells enhance human immunodeficiency virus type 1 replication in CD4+ T cells in a Nef-dependent manner in vitro and in vivo.
    Choi J; Walker J; Boichuk S; Kirkiles-Smith N; Torpey N; Pober JS; Alexander L
    J Virol; 2005 Jan; 79(1):264-76. PubMed ID: 15596822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
    Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
    Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct and indirect mechanisms mediating apoptosis during HIV infection: contribution to in vivo CD4 T cell depletion.
    Gougeon ML; Laurent-Crawford AG; Hovanessian AG; Montagnier L
    Semin Immunol; 1993 Jun; 5(3):187-94. PubMed ID: 8102263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
    Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
    J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune restoration and CD4+ T-cell function with antiretroviral therapies.
    Lederman MM
    AIDS; 2001 Feb; 15 Suppl 2():S11-5. PubMed ID: 11424971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.